Open an account

Spectral AI

MDAI · NASDAQ

$1.51−$0.01 (−0.66%)TodayMarket closed ·
Prev close $1.52

About MDAI

Spectral AI, Inc. is a predictive artificial intelligence company. The company is headquartered in Dallas, Texas and currently employs 65 full-time employees. The company went IPO on 2021-02-12. The firm's DeepView platform is a predictive device that offers clinicians an objective and immediate assessment of a wound healing potential prior to treatment or other medical intervention. DeepView platform that combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential. The company is non-invasive, non-radiation, non-laser and does not require the use of injectable dye. The DeepView AI- Burn software is used with the DeepView SnapShot imaging device, and it is intended to be used as an adjunctive tool to aid healthcare providers in the assessment of burn wound healing potential by differentiating non-healing from healing burned tissue within an image.

Employees
65
Headquarters
Dallas, Texas
Listed
Feb 12, 2021
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
spectral-ai.com

MDAI key statistics

Market cap
48.60M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
133.96K
Volume
61.78K
Open price
$1.53
High today
$1.54
Low today
$1.48
52 Week high
$2.97
52 Week low
$1.18

Spectral AI (MDAI) at a glance

Spectral AI (MDAI) last traded at $1.51, with a market cap of 48.60M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $1.48 and $1.54. The current price is 2.0% above the day's low and 1.9% below its high.

Volume so far is 61.78K shares, below the average of 133.96K shares a day.

Over the past year Spectral AI has ranged from $1.18 to $2.97, and now sits 18% of the way up that range.

Spectral AI met or beat analyst EPS estimates in 4 of the last 8 quarters. In Q2 FY26 it reported -$0.13 per share against an estimate of -$0.1377.

The average analyst price target is $5.23, 246.2% above the current price, from 1 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 1 analyst rating say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 4 analystsAvg $5.23
Low
$4.04
Now
$1.51
High
$6.56

MDAI earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 4 of the last 8 quarters, by 89.1% on average.

  1. Q3 FY24: reported -$0.08 per share against an estimate of -$0.1683
  2. Q4 FY24: reported -$0.41 per share against an estimate of -$0.1224
  3. Q1 FY25: reported $0.11 per share against an estimate of -$0.1326
  4. Q2 FY25: reported -$0.31 per share against an estimate of -$0.0748
  5. Q3 FY25: reported -$0.13 per share against an estimate of -$0.085
  6. Q4 FY25: reported $0.02 per share against an estimate of -$0.1292
  7. Q1 FY26: reported -$0.11 per share against an estimate of -$0.0918
  8. Q2 FY26: reported -$0.13 per share against an estimate of -$0.1377

MDAI news

  • Press releaseGlobe Newswire

    Spectral AI to Present at H.C. Wainwright 28th Annual Global Investment Conference

  • Press releaseGlobe Newswire

    Spectral AI Announces 2026 Second Quarter Financial Results

  • Press releaseGlobe Newswire

    Spectral AI Schedules 2026 Second Quarter Financial Results and Conference Call

  • Press releaseGlobe Newswire

    Real-Time Intoxication Detection Platforms Target Expanding Multibillion-Dollar Healthcare Opportunities

  • Press releaseGlobe Newswire

    Spectral AI Announces 2026 First Quarter Financial Results

  • Press releaseGlobe Newswire

    Spectral AI Schedules 2026 First Quarter Financial Results and Conference Call

  • Press releaseGlobe Newswire

    Spectral AI Announces 2025 Fourth Quarter and Full Year Financial Results and Introduces Revenue Guidance for 2026

  • 12 Health Care Stocks Moving In Wednesday's After-Market Session

Similar companies

Companies in the same industry as Spectral AI

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.